TR15 Tirzepatide 15mg × 10 Vials white lyophilized powder vial label

Tirzepatide 15mg

Name: Tirzepatide 15mg - PeptaCo
SKU: TR15

Tirzepatide 15mg (Catalog No. TR15) is a research-grade Dual GIP/GLP-1 receptor agonist supplied by PeptaCo for qualified laboratory applications. This catalog specification provides 15mg per vial in lyophilized powder format. Tirzepatide is widely referenced in metabolic signaling and receptor pharmacology research. PeptaCo supplies this compound with batch-specific documentation and COA available upon request.

Cat. No. TR15

Specification 15mg × 10 vials

Form Lyophilized powder

Category GLP-1 & Metabolic

Request a Quote Request Current COA

Documentation support COA upon request

B2B supply Bulk quotation available

Traceability Batch-specific records

Important Note

This product is intended for qualified laboratory research and analytical applications. It is not for human or veterinary use. Specifications and documentation vary by batch — please contact PeptaCo for the current batch information.

Molecular Profile

What is Tirzepatide?

Tirzepatide is a synthetic research peptide engineered to engage both GLP-1 and GIP receptors. It is a subject of active investigation in metabolic and endocrinology research. PeptaCo provides several dosage-form specifications for qualified laboratory customers.

This listing covers the 15mg × 10 vials configuration under catalog number TR15. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.

Compound data

Chemical Structure & Purity Profile

Purity >99% Peptide Content >98%

Chemical Structure

PubChem CID 156588324

View Tirzepatide PubChem record

Type	Dual GIP/GLP-1 receptor agonist
PubChem CID	156588324
HPLC Purity	>99% (batch-specific COA available)
Peptide Content	>98% peptide content — not just chromatographic purity
Documentation	Current batch COA and analytical package available upon request

Why peptide content matters: some suppliers may report high chromatographic purity while delivering lower actual peptide content. PeptaCo specifies both >99% purity and >98% peptide content for qualified B2B supply.

Product Specifications

Product Name	Tirzepatide
Catalog Number	TR15
Specification	15mg × 10 vials
Product Form	Lyophilized powder
Category	GLP-1 & Metabolic
Documentation	Batch-specific COA available upon request
Storage	Refer to batch-specific product documentation
Intended Market	Qualified B2B and research customers

Quality & Analytical Documentation

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package.

◦ Identity Confirmation — available by request

◦ Purity Analysis — available by request

◦ Batch Traceability — provided with every order

◦ Additional Testing — product- and batch-dependent

Need Current Batch Documentation or Bulk Pricing?

Tell us the product SKU, quantity, documentation requirements, and destination country. The PeptaCo team will prepare the applicable quotation and document package.

Request a Quote Ask About OEM/ODM

Description
Reviews (0)

Description

Product Overview

Tirzepatide is a synthetic dual-agonist peptide supplied by PeptaCo for qualified laboratory research. It is engineered to interact with both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor pathways, making it a valuable tool for studying metabolic signaling mechanisms and receptor pharmacology.

Key Product Details

Product Name: Tirzepatide
Specification: As listed per catalog variant
Product Form: Lyophilized powder
Category: Metabolic Research Peptides — Dual GIP/GLP-1 Receptor Agonist">GLP-1 Receptor Agonist
Receptor Targets: GLP-1 receptor, GIP receptor

Chemical Identity

Tirzepatide is a linear peptide-based research compound with a modified sequence designed for dual receptor engagement. The molecule incorporates structural modifications to enhance binding affinity at both GLP-1 and GIP receptors. Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈. Molecular Weight: ~4813 Da. PubChem CID: 156588324.

Research Context

Tirzepatide is actively studied in metabolic and endocrinology research for its dual-agonist mechanism, enabling investigation of glucose dynamics, receptor signaling, and peptide-mediated biological processes. The dual-pathway engagement makes it particularly valuable for comparative receptor pharmacology studies. PeptaCo supplies Tirzepatide in multiple specifications (5mg, 10mg, 15mg, 20mg, 30mg, 60mg) to support diverse research protocols.

Storage and Handling

Store in a cool, dry place away from direct light. Follow batch-specific storage instructions provided with the certificate of analysis. Avoid repeated freeze-thaw cycles. Handle using standard laboratory practices.

Documentation and Quality

Batch-specific analytical documentation is available to qualified customers upon request. Contact PeptaCo with the product SKU and required quantity to request the current documentation package, which may include identity confirmation, purity analysis, and batch traceability records.

Important Notice

This product is supplied for qualified laboratory research and analytical applications only. It is not for human or veterinary use. Product specifications may vary by batch. Appearance, analytical results, counter-ion information, and other release specifications should be confirmed against the certificate issued for the current batch.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide 15mg”